Egide (ALGID) H1 2024 earnings summary

Executive summary

• Consolidated revenue for H1 2024 was €15.4M, down 19.6% year-over-year, mainly due to a sharp drop in orders from a key client, export license withdrawal, and reduced sales in China and the US.

• Cost reduction measures, especially in personnel, and margin improvements limited the net loss increase to €1.4M despite the revenue decline.

• New market segments (thermal batteries, missile ignition devices) are being developed but faced delays due to lengthy client qualification processes.

• Announced €1.8M capital increase with strong subscription commitments covering 83% of the issue.

• Leadership changes include the appointment of a new CEO and Chairman, signaling a new strategic phase.

Financial highlights

• Revenue: €15.43M in H1 2024 vs €19.19M in H1 2023 (-19.6% year-over-year).

• Net loss: €1.4M in H1 2024 vs €0.9M in H1 2023.

• Gross margin improved to 65.1% from 61.9% year-over-year.

• Operating loss: €936K in H1 2024 vs €335K in H1 2023.

• Cash at period end: €1.16M, down from €3.2M at end-2023.

Outlook and guidance

• Annual revenue for 2024 is expected to be below initial expectations due to ongoing supply and production challenges and continued weakness from key clients.

• Diversification into new markets is expected to benefit earnings from Q4 2024 or 2025.

• Management remains confident in long-term prospects due to investments and modernization.